[go: up one dir, main page]

NO991733D0 - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733D0
NO991733D0 NO991733A NO991733A NO991733D0 NO 991733 D0 NO991733 D0 NO 991733D0 NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 D0 NO991733 D0 NO 991733D0
Authority
NO
Norway
Prior art keywords
preparation
intravenous administration
igm
igm preparation
intravenous
Prior art date
Application number
NO991733A
Other languages
English (en)
Other versions
NO991733L (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (2)

Publication Number Publication Date
NO991733D0 true NO991733D0 (no) 1999-04-13
NO991733L NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (no)
EP (1) EP0835880A1 (no)
JP (1) JP2001504092A (no)
KR (1) KR20000048826A (no)
CN (1) CN1233258A (no)
AU (1) AU725134B2 (no)
BR (1) BR9712306A (no)
CA (1) CA2266848A1 (no)
CZ (1) CZ125599A3 (no)
HU (1) HUP0001069A3 (no)
ID (1) ID21364A (no)
IL (1) IL129383A0 (no)
NO (1) NO991733L (no)
NZ (1) NZ334885A (no)
PL (1) PL332774A1 (no)
RU (1) RU2191032C2 (no)
SI (1) SI9720063A (no)
SK (1) SK46699A3 (no)
WO (1) WO1998016558A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
DE602004030451D1 (de) 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
EP1688432B1 (en) * 2003-10-09 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Igm high concentration stabilized solution
EP1686137A4 (en) * 2003-10-09 2009-10-28 Chugai Pharmaceutical Co Ltd PROCESS FOR STABILIZING PROTEIN SOLUTIONS
ES2409844T3 (es) * 2006-01-30 2013-06-28 Grifols Therapeutics Inc. Metodo para el tratamiento y la profilaxis de enfermedades relacionadas con la deposicion de amiloide utilizando IgM
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
CA2760493A1 (en) * 2008-05-12 2009-11-19 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
WO2015187779A1 (en) 2014-06-03 2015-12-10 Xbiotech, Inc. Compositions and methods for treating and preventing staphylococcus aureus infections
AU2021303496A1 (en) * 2020-07-10 2023-02-02 Grifols Worldwide Operations Limited Method for obtaining a composition comprising human plasma-derived immunoglobulin M

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
DE3927112C1 (no) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
BR9712306A (pt) 1999-08-31
SK46699A3 (en) 2000-06-12
PL332774A1 (en) 1999-10-11
RU2191032C2 (ru) 2002-10-20
HUP0001069A2 (hu) 2000-10-28
AU725134B2 (en) 2000-10-05
CN1233258A (zh) 1999-10-27
NZ334885A (en) 2000-09-29
KR20000048826A (ko) 2000-07-25
SI9720063A (sl) 1999-08-31
HUP0001069A3 (en) 2000-12-28
CZ125599A3 (cs) 1999-07-14
ID21364A (id) 1999-05-27
IL129383A0 (en) 2000-02-17
NO991733L (no) 1999-06-11
US6136312A (en) 2000-10-24
JP2001504092A (ja) 2001-03-27
EP0835880A1 (de) 1998-04-15
CA2266848A1 (en) 1998-04-23
AU4449597A (en) 1998-05-11
WO1998016558A1 (de) 1998-04-23

Similar Documents

Publication Publication Date Title
NO175287C (no) Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat
NO913234L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO914667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO903088D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO910395L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO308580B1 (no) Anvendelse av kondenserte cykliske forbindelser for fremstilling av en antihypertriglyceridemisk medisin
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO913008D0 (no) Fremgangsmaate for fremstilling av fenylacetamid-derivater.
NO991733D0 (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
NO912797L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO911065L (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
NO930574L (no) Fremgangsmaate for fremstilling av desfluran
NO914053D0 (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
NO304110B1 (no) FremgangsmÕte for fremstilling av glutardialdehyd
NO913187L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO914985D0 (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO931839D0 (no) Fremgangsmaate for fremstilling av pergolid
NO961008D0 (no) Fremgangsmåte for fremstilling av cykliske cis-1-amino-2-alkanoler
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO911672L (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO903397L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO914452D0 (no) Fremgangsmaate for fremstilling av isokinolinderivater
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO921037D0 (no) Fremgangsmaate for fremstilling av polyetersyklopolyoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application